Unfortunately, such radiation-induced increases in anti-tumor immunity are counterbalanced by an increase in immunosuppression mediated by HIFα levels (HIF-1α and HIF-2α), which are significantly upregulated in SABR-treated tumors because of increased tumor hypoxia as a result of radiation-induced stress and vascular damage. Here, HIF1A is linked to neoplasm.